研究・業績

業績

原著論文

英文

  • Clinical characteristics of cancer-associated myositis complicated by interstitial lung disease: a large-scale multicentre cohort study
    Kaneko Y, Nunokawa T, Taniguchi Y, Yamaguchi Y, Gono T, Masui K, Kawakami A, Kawaguchi Y, Sato S and Kuwana M; JAMI investigators.
    Rheumatology (Oxford). 2020; 59(1):112-119.
  • Comparison of cytokine profiles between anti-ARS antibody-positive interstitial lung diseases and those with anti-MDA-5 antibodies
    Asakawa K, Yoshizawa K, Aoki A, Kimura Y, Tanaka T, Ohashi K, Hayashi M, Kikuchi T, Sato S, Takada T.
    Clin Rheumatol. 2020;39(7):2171-2178.
  • Clinical, radiological, and pathological features of anti-asparaginyl tRNA synthetase antibody-related interstitial lung disease
    Aiko N, Yamakawa H, Iwasawa T, Takemura T, Okudela K, Kitamura H, Hagiwara E, Ikeda S, Baba T, Iso S, Yamaguchi Y, Kondo Y, Kurabayashi T, Ohashi K, Sato S, Ogura T.
    Respir Investig. 2020;58(3):196-203.
  • Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease
    Nishina N, Sato S, Masui K, Gono T, Kuwana M.
    RMD Open. 2020;6(2):e001202.
  • Evaluation of usefulness in surfactant protein D as a predictor of mortality in myositis-associated interstitial lung disease
    Kaieda S, Gono T, Masui K, Nishina N, Sato S, Kuwana M, A Multicenter Retrospective Cohort of Japanese Patients with Myositis-associated ILD (JAMI) investigators.
    PLoS One. 2020 Jun 11;15(6):e0234523.doi: 10.1371.
  • Clinicopathological evaluation of methotrexate-associated lymphoproliferative disorders with special focus on Epstein-Barr virus-positive mucocutaneous lesions
    Shiraiwa S, Kikuti YY, Carreras J, Hara R, Aoyama Y, Ogiya D, Suzuki R, Toyosaki M, Ohmachi K, Ogawa Y, Kawada H, Sato S, Nakamura N, Ando K.
    J Clin Exp Hematop. 2020 Dec 15;60(4):159-168. doi: 10.3960/jslrt.20041. Epub 2020 Nov 4. PMID: 33148934.
  • Emerging Therapeutics in Idiopathic Inflammatory Myopathy
    Sato S.
    Indian J Rheumatol. 2020. DOI: 10.4103/injr.injr_124_20.

学会発表

国際

  • The management of rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis in Japans
    Sato S.
    APLAR. 2020.10
  • Pharmacodynamics of methotrexate as methotrexate-polyglutamates concentrations in rheumatoid arthritis; interim data from MIRACLE Study conducted in Japan, Korea and Taiwan
    Tamai H, Kaneko Y, Kameda H, Kuwana M, Okano Y, Ishii T, Ikeda K, Taguchi H, Sato S, Miyamoto T, Sugiyama E, Yasuoka H, Kojima T, Park S. H., Shin K, Baek H. J., Lee Y. J., Choi I. A., Kim J, Hsu P, Kuo C, Huang C, Weng M, Tsai W, Cheng T, Taninaga T, Mori M, Miyagishi H, Sato Y, Takeuchi T.
    APLAR. 2020.10
  • Efficacy of Early Initiation of Plasma Exchange Therapy for a Patient with Anti-MDA5 Autoantibody-Positive Dermatomyositis Developing Refractory Rapidly Progressive Interstitial Lung Disease
    Sasaki N, Ishii A, Shimura K, Kojima A, Sugiyama M, Nakagome Y, Izumi Y, Hirano K, Sasaki S, Kurabayashi T, Hosono Y, Yamada C, Sato S.
    The 2020 Annual scientific meeting of American College of Rheumatology. 2020.11

ページトップへ戻る